PlainRecalls
FDA Devices Moderate Class II Terminated

Abbott ARCHITECT cSystems ICT Module, REF 09D28-03. Product Usage: The ARCHITECT cSystems ICT (Integrated Chip Technology) is used for the quantitation of sodium, potassium, and chloride in human serum, plasma, or urine.

Reported: May 15, 2019 Initiated: August 28, 2018 #Z-1296-2019

Product Description

Abbott ARCHITECT cSystems ICT Module, REF 09D28-03. Product Usage: The ARCHITECT cSystems ICT (Integrated Chip Technology) is used for the quantitation of sodium, potassium, and chloride in human serum, plasma, or urine.

Reason for Recall

There is a potential to generate falsely elevated serum or plasma chloride results when using the product.

Details

Recalling Firm
Abbott Laboratories, Inc
Units Affected
99 modules/kits
Distribution
Worldwide Distribution - US Nationwide in the states of AR, CA, CT, FL, IA, IN, LA, MA, MD, MS, NJ, NY, PA, SC, TX, VT, WA, and WV. There was government distribution and no military distribution. Foreign distribution was made to Australia, China, Hong Kong, and New Zealand.
Location
Irving, TX

Frequently Asked Questions

What product was recalled?
Abbott ARCHITECT cSystems ICT Module, REF 09D28-03. Product Usage: The ARCHITECT cSystems ICT (Integrated Chip Technology) is used for the quantitation of sodium, potassium, and chloride in human serum, plasma, or urine.. Recalled by Abbott Laboratories, Inc. Units affected: 99 modules/kits.
Why was this product recalled?
There is a potential to generate falsely elevated serum or plasma chloride results when using the product.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 15, 2019. Severity: Moderate. Recall number: Z-1296-2019.